Skip to content

Clinical trials

Phase 2 Hypersensitivity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypersensitivity Phase: Phase 2 Clear all

119 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20033
20042
200512
20067
20077
20088
200913
20107
20113
20128
20135
20148
20153
20165
20171
20182
20192
20202
20213
20222
20231
20244
20253
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed90
Terminated13
Recruiting10
Unknown status3
Active, not recruiting2
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute of Allergy and Infectious Diseases (NIAID)13
Allergy Therapeutics10
Circassia Limited7
ALK-Abelló A/S5
Aerovance, Inc.4
Genentech, Inc.4
Roxall Medicina España S.A4
Johns Hopkins University3
Massachusetts General Hospital3
Aimmune Therapeutics, Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypersensitivity119
Asthma22
Hypersensitivity, Immediate15
Rhinitis, Allergic15
Rhinitis, Allergic, Seasonal14
Rhinitis13
Food Hypersensitivity11
Peanut Hypersensitivity9
Immune System Diseases7
Eczema5

Trials

Showing 51 to 75 of 119. Each trial links to its page on Pharma Observatory.

19 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.